Figure 2

Heatmap with copy number alteration profile in the chromosomal regions used by the different phases of the predictive genomic model, (A) in patients with vs. without recurrence/metastasis - first phase of the predictive model; (B) in patients without recurrence and those unidentifiable - second phase of the predictive model; (C) in patients with recurrence and those unidentifiable - third phase of the predictive model.